4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)
4:4 阿片类药物暴露和神经发育的调查 (iOPEN)
基本信息
- 批准号:10321798
- 负责人:
- 金额:$ 22.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-30 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAddressAffectAgeAttentionBaseline SurveysBehavioralBiological FactorsBirthBrainCOVID-19COVID-19 diagnosisCOVID-19 pandemicCessation of lifeChildChild DevelopmentClassificationClinical ManagementCoronavirusCountryDataData CollectionDevelopmentDevelopmental Delay DisordersDiagnosisDiseaseEmotionalEnvironmentEnvironmental Risk FactorEventExposure toFetal DistressGoalsHealthHealth behaviorHumanHuman DevelopmentIncidenceIncomeIndividualIndividual DifferencesInfantInfant DevelopmentInfectionInflammationInfrastructureInvestigationLifeMagnetic Resonance ImagingMeasuresMental HealthMothersMyelinNeurocognitiveNew York CityNewborn InfantOutcomeOutcome MeasureOutcome StudyPerinatalPopulationPregnancyPregnant WomenPremature LaborProtocols documentationPsychosocial FactorPsychosocial StressPublic HealthReceiver Operating CharacteristicsRecording of previous eventsReportingResearchResearch PersonnelRiskRisk FactorsSARS-CoV-2 infectionSeriesSeverity of illnessSocietiesStressSurveysSystemTestingThird Pregnancy TrimesterUnited States National Institutes of HealthValidationVariantVertical Disease TransmissionVulnerable PopulationsWaterWomanWorkantenatalcaregivingcohortcontextual factorsexperiencehigh dimensionalityin uteroinfancyinfant outcomemultimodalitymyelinationnegative affectneurobehavioralneurodevelopmentnoveloffspringopioid exposurepandemic diseasepostnatalpregnantprenatalprospectiveprotective factorspsychobiologicrecruitrelating to nervous systemrepositoryresiliencesextool
项目摘要
PROJECT SUMMARY
The SARS-CoV-2 (COVID-19) pandemic represents the most significant environmental event in living history.
Sixty-eight million people worldwide have fallen ill to this disease, and 1.5 million people have died. Amongst
those at greatest risk are society’s most vulnerable populations, including pregnant women and their children.
It is unclear whether and how COVID-19 illness during pregnancy impacts the development of the child, as well
as whether the timing of illness has any influence over this effect. It is also unknown whether environmental
factors may mitigate observed outcomes. The present study will examine neurobehavioral trajectories in 100
children, half of whom will be born to women with COVID-19 infection diagnoses during pregnancy. Infants will
undergo prospective longitudinal assessments at 1-, 6-, 9- and 12-months, including MRI 1 month (N = 50) and
12 months (N = 100). Our central hypotheses are that (1) perinatal COVID-19 leads to differences in infant
attention, affect, myelination, and systems-level neural functional connectivity and that (2) earlier timing of
prenatal infection and illness severity increase risk for developmental delay. We will explore specific
environmental factors with potential influence over the association between maternal prenatal COVID-19
infection and child outcomes, particularly pre- and postnatal psychological health and partner support. We will
thus be able to meaningfully evaluate whether, and how, prenatal COVID-19 illness modifies neurobehavioral
development of infants and will address how variation in maternal psychobiological health influences observed
associations.
项目概要
SARS-CoV-2 (COVID-19) 大流行是人类历史上最重大的环境事件。
全世界有 6800 万人患上这种疾病,其中 150 万人死亡。
面临最大风险的是社会最弱势群体,包括孕妇及其子女。
目前尚不清楚怀孕期间的 COVID-19 疾病是否以及如何影响孩子的发育
发病时间是否对这种效果有影响尚不清楚。
本研究将检查 100 种因素的神经行为轨迹。
儿童,其中一半是在怀孕期间诊断出感染了 COVID-19 的妇女所生的。
在 1、6、9 和 12 个月时进行前瞻性纵向评估,包括 1 个月的 MRI (N = 50) 和
12 个月 (N = 100)。我们的中心假设是 (1) 围产期 COVID-19 导致婴儿差异。
注意力、情感、髓鞘形成和系统级神经功能连接,以及 (2) 较早的时间
产前感染和疾病严重程度会增加发育迟缓的风险,我们将探讨具体情况。
对孕产妇产前 COVID-19 之间的关联具有潜在影响的环境因素
感染和儿童结局,特别是产前和产后心理健康和伴侣支持。
因此能够有意义地评估产前 COVID-19 疾病是否以及如何改变神经行为
婴儿的发育,并将解决观察到的母亲心理生物健康变化如何影响的问题
协会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Veerle Bergink其他文献
Veerle Bergink的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Veerle Bergink', 18)}}的其他基金
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence
产前母体感染和炎症对青春期人脑发育和精神病理学的影响
- 批准号:
10296635 - 财政年份:2021
- 资助金额:
$ 22.89万 - 项目类别:
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence
产前母体感染和炎症对青春期人脑发育和精神病理学的影响
- 批准号:
10468261 - 财政年份:2021
- 资助金额:
$ 22.89万 - 项目类别:
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence
产前母体感染和炎症对青春期人脑发育和精神病理学的影响
- 批准号:
10640239 - 财政年份:2021
- 资助金额:
$ 22.89万 - 项目类别:
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
怀孕期间停用抗抑郁药后复发的风险(R-DAP 研究)
- 批准号:
10569044 - 财政年份:2020
- 资助金额:
$ 22.89万 - 项目类别:
EXPOSURE TO TETRACYCLINE ANTIBIOTICS AND THE POTENTIAL PROTECTIVE EFFECT ON SCHIZOPHRENIA RISK.
接触四环素抗生素及其对精神分裂症风险的潜在保护作用。
- 批准号:
10039207 - 财政年份:2020
- 资助金额:
$ 22.89万 - 项目类别:
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
怀孕期间停用抗抑郁药后复发的风险(R-DAP 研究)
- 批准号:
10117285 - 财政年份:2020
- 资助金额:
$ 22.89万 - 项目类别:
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
怀孕期间停用抗抑郁药后复发的风险(R-DAP 研究)
- 批准号:
10334499 - 财政年份:2020
- 资助金额:
$ 22.89万 - 项目类别:
4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)
4:4 阿片类药物暴露和神经发育的调查 (iOPEN)
- 批准号:
10020516 - 财政年份:2019
- 资助金额:
$ 22.89万 - 项目类别:
4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)
4:4 阿片类药物暴露和神经发育的调查 (iOPEN)
- 批准号:
9899554 - 财政年份:2019
- 资助金额:
$ 22.89万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
- 批准号:
10797938 - 财政年份:2023
- 资助金额:
$ 22.89万 - 项目类别:
Developing RNA Vaccines to Treat Peanut Hypersensitivity
开发治疗花生过敏的 RNA 疫苗
- 批准号:
10570339 - 财政年份:2023
- 资助金额:
$ 22.89万 - 项目类别:
The role of pathogen-experienced macrophage subsets in mediating lung immunity and heterologous protection
经历病原体的巨噬细胞亚群在介导肺免疫和异源保护中的作用
- 批准号:
10753773 - 财政年份:2023
- 资助金额:
$ 22.89万 - 项目类别:
Multiplexed detection of cell-free M. Tuberculosis DNA and its drug-resistant variants in blood
血液中无细胞结核分枝杆菌 DNA 及其耐药变异体的多重检测
- 批准号:
10639855 - 财政年份:2023
- 资助金额:
$ 22.89万 - 项目类别:
IgG and FcR Characterization in Small Animal Models of RespiratoryDisease
呼吸道疾病小动物模型中的 IgG 和 FcR 表征
- 批准号:
10678229 - 财政年份:2023
- 资助金额:
$ 22.89万 - 项目类别: